National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of “Moderate Buy” from Analysts

National Health Investors, Inc. (NYSE:NHI) has received an average rating of “Moderate Buy” from the seven analysts that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $86.6667.

Several equities analysts recently weighed in on NHI shares. Cantor Fitzgerald set a $85.00 target price on National Health Investors in a research report on Monday, January 5th. Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a research note on Tuesday, January 20th. National Bank Financial set a $85.00 price objective on shares of National Health Investors in a report on Tuesday, January 20th. Wells Fargo & Company boosted their target price on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Finally, Truist Financial upped their price target on shares of National Health Investors from $85.00 to $92.00 and gave the stock a “buy” rating in a research report on Thursday, March 12th.

National Health Investors Stock Up 1.3%

NHI stock opened at $86.28 on Tuesday. The stock has a market capitalization of $4.17 billion, a P/E ratio of 28.57, a PEG ratio of 4.61 and a beta of 0.65. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. National Health Investors has a one year low of $66.41 and a one year high of $91.38. The company has a 50 day moving average price of $83.64 and a two-hundred day moving average price of $79.47.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The business had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. During the same period in the prior year, the company earned $1.24 EPS. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. As a group, sell-side analysts expect that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Tuesday, March 31st. National Health Investors’s dividend payout ratio is presently 121.85%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its position in National Health Investors by 305.2% during the second quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock valued at $84,389,000 after acquiring an additional 906,479 shares during the period. Norges Bank purchased a new position in shares of National Health Investors in the 4th quarter worth about $55,301,000. M Holdings Securities Inc. acquired a new position in shares of National Health Investors in the 2nd quarter valued at about $36,607,000. Freestone Grove Partners LP acquired a new position in shares of National Health Investors in the 4th quarter valued at about $21,869,000. Finally, Adage Capital Partners GP L.L.C. purchased a new stake in shares of National Health Investors during the 4th quarter worth about $19,856,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.